Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000252295 | SCV000305504 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001723842 | SCV001950496 | benign | not provided | 2021-05-04 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 19641441, 9323320, 30218069, 25766270) |
Breakthrough Genomics, |
RCV001723842 | SCV005275349 | benign | not provided | criteria provided, single submitter | not provided | ||
Bruce Budowle Laboratory, |
RCV001029692 | SCV001192478 | drug response | Tramadol response | 2018-04-28 | no assertion criteria provided | research | |
Diagnostic Laboratory, |
RCV000252295 | SCV001740422 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000252295 | SCV001809723 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000252295 | SCV001952573 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000252295 | SCV001968508 | benign | not specified | no assertion criteria provided | clinical testing | ||
Beijing Key Laboratory of Neuropsychopharmacology, |
RCV003313783 | SCV002822981 | uncertain risk allele | methamphetamine use disorder | 2023-01-16 | no assertion criteria provided | case-control |